Coronavirus Notebook: UK To Speed Up Trials Of New Drugs, Expands Use Of Tocilizumab
AstraZeneca and BioNTech are both boosting production of their vaccines in Europe, and the first batches of Comirnaty have arrived in Australia and New Zealand.
You may also be interested in...
New government funding to boost vaccine manufacturing and research into variant vaccines is being made available as part of the UK’s ambitious plans for a partnership to accelerate the availability of vaccines and other products for future pandemics.
Politics are never far from the surface where coronavirus vaccines are concerned, as demonstrated by recent comments by the Sputnik V developers.
The RECOVERY trial has found Actemra to help cut deaths and speed recovery – and UK doctors are not waiting for Roche to complete own studies.